HAS Healthcare Advanced Synthesis Acquires Cerbios-Pharma
Deal News | Mar 31, 2025 | PR Newswire Cision 65 Equity Partners; HAS Healthcare Advanced Synthesis
HAS Healthcare Advanced Synthesis SA (HAS) has announced its intention to acquire Cerbios-Pharma SA with the support of 65 Equity Partners. This acquisition aims to create a leading international group in the Contract Development and Manufacturing Organization (CDMO) sector, leveraging the combined production capabilities and technical expertise of both companies. 65 Equity Partners plays a significant role in the transaction, acquiring a 40% share in the new group, and aims to drive long-term growth and innovation. This strategic move will enable HAS and Cerbios to meet increasing global demands for complex therapies and consolidate their position in the pharmaceutical industry. The merge is subject to regulatory approvals and underscores a commitment to the Ticino region in Switzerland. Financial and legal advice for the transaction was provided by Rothschild & Co, Bär & Karrer, EY, UBS AG, Ropes & Gray, and others.
Sectors
- Pharmaceuticals
- Private Equity
- Healthcare
Geography
- Switzerland – Both HAS Healthcare Advanced Synthesis and Cerbios-Pharma are headquartered in Switzerland.
- Global – The companies involved have a global operational scope and market.
Industry
- Pharmaceuticals – The article discusses companies involved in the manufacturing and development of pharmaceutical products.
- Private Equity – The acquisition is supported by 65 Equity Partners, a global investment firm.
- Healthcare – Both HAS and Cerbios operate within the healthcare sector, focusing on pharmaceutical ingredients.
Financials
- 40% – 65 Equity Partners will have an approximately 40% share in the new group formed by HAS and Cerbios.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| HAS Healthcare Advanced Synthesis SA | Acquirer | Company | An international leader in the development and production of pharmaceutical ingredients. |
| Cerbios-Pharma SA | Target | Company | A globally recognized manufacturer of chemical and biological API. |
| 65 Equity Partners | Investor | Company | A global investment firm supporting family businesses and entrepreneurs. |
| Rothschild & Co | Financial Advisor | Company | Provided financial advisory services for the transaction. |
| Bär & Karrer | Legal Advisor | Company | Provided legal advisory services for HAS. |
| EY | Accounting and Tax Advisor | Company | Provided accounting and tax advisory services for HAS. |
| UBS AG | Financial Advisor | Company | Provided financial advisory services for 65 Equity Partners. |
| Ropes & Gray | Legal Advisor | Company | Provided legal advisory services for 65 Equity Partners. |
| Walder Wyss | Legal Advisor | Company | Provided legal advisory services for 65 Equity Partners. |